Image

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Study on long-term safety of a treatment for prostate cancer.

Recruiting
18 years and older
Male
Phase 4
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Overview: This study is about understanding the long-term safety of a treatment called lutetium (177Lu) vipivotide tetraxetan, also known as AAA617, for adults with prostate cancer. It does not involve giving any new treatment. Instead, it focuses on checking up on the health of people who have already received AAA617 in past clinical trials.

Study Details: Participants will visit the study center every 6-8 months. These visits will happen for up to 10 years. During these visits, doctors will monitor any health issues that might be connected to AAA617. This study is for those who have already been part of other trials and received the AAA617 treatment.

  • Participants will not receive new treatments, just health check-ups.
  • Visits are every 6-8 months for up to 10 years, starting from first treatment.
  • Must have already participated in a previous trial with AAA617.

Eligibility: You must have previously been part of a prostate cancer trial with AAA617 and agree to join this follow-up study. If health reasons prevent you from completing check-ups, you cannot join.

Print
Study details
    Prostate Cancer

NCT05803941

Novartis Pharmaceuticals

26 April 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.